The socio-economic landscape of biotechnology in Spain.: A comparative study using the innovation system concept

被引:13
作者
Díaz, V
Muñoz, E
de los Monteros, JE
Senker, J
机构
[1] CSIC, Unidad Polit Comparadas, Grp Ciencia Technol & Sociedad, Madrid 28014, Spain
[2] Univ Sussex, SPRU Sci & Technol Policy Res, Brighton BN1 9RF, E Sussex, England
关键词
biotechnology sector; European comparison; regional influences; spin-off firms; industrial diversification;
D O I
10.1016/S0168-1656(02)00083-4
中图分类号
Q81 [生物工程学(生物技术)]; Q93 [微生物学];
学科分类号
071005 ; 0836 ; 090102 ; 100705 ;
摘要
Biotechnology is becoming a crucial factor for the innovation strategies of the industrialised countries. Thus, the analysis of the sector is gaining relevance for the identification of the technological strength and potential of a country (or region) in a context of globalisation. A specific national case study may serve for more general comparative analyses. We have selected the case of Spain as illustrative of the complexity and differences existing in Europe. By using the analytical framework of the "national systems of innovation" concept, we have performed a multistep analysis of the biotechnology sector in Spain, focussing first on regions of Madrid and Cataluna which together account for more than 50% of the sector in Spain. The firms in both regions have followed a common strategy based on diversification and investment in R&D and innovation, so as to be able to compete in an international and competitive environment. There are, however, some interesting differences between the two subsectors; the one from Cataluna being more based on industrial traditions, and the one from Madrid characterised by the emergence of more specialised firms. The study has been extended to the remainder of Spanish firms for comparative purposes. The case of Spain is illustrative of the divergences existing in the biotechnology sector in Europe. A comparison is made with the structural and organisational characteristics of the biotechnology sector in several European countries. It shows that there is diversity in the pattern of commercialisation between countries and within regions of countries. Understanding these differences may assist the design of appropriate policies to promote the development of biotechnology in Europe. (C) 2002 Elsevier Science B.V. All rights reserved.
引用
收藏
页码:25 / 40
页数:16
相关论文
共 8 条
[1]  
ALBERT A, 1997, SPANISH RES GROUPS E
[2]  
BRACZYK HJ, 1998, REGIONAL INNOVATIONS
[3]  
*EUR COMM, 1999, INV PUBL BIOT R D PR
[4]  
Lundvall B.A, 1992, National systems of innovation Towards a theory of innovation and interactive learning
[5]  
MALERBA F, 1999, UNPUB SECTORAL SYSTE
[6]  
Nelson R.R., 1993, NATL INNOVATION SYST, P3
[7]  
Rosenberg N., 1991, SCI PUBL POLICY, V18, P335, DOI 10.1093/spp/18.6.335
[8]  
SAVIOTTI PP, 1998, BIOTECHNOLOGY COMPET